compounds 30, 34 and 36 (CEREP Inc)
90
Structured Review
CEREP Inc
compounds 30, 34 and 36
Compounds 30, 34 And 36, supplied by CEREP Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/compounds+30%2C+34+and+36/compounds+30++34+and+36/pm28682065-127-0-22
Average 90 stars, based on 1 article reviews
Compounds 30, 34 And 36, supplied by CEREP Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/compounds+30%2C+34+and+36/compounds+30++34+and+36/pm28682065-127-0-22
Average 90 stars, based on 1 article reviews
compounds 30, 34 and 36 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Discovery of Clinical Candidate 4-[2-(5-Amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): Design and Optimization of Diaryl Ether Aryl Sulfonamides as Selective Inhibitors of Na V 1.7. Article Snippet: A series of acidic diaryl ether heterocyclic sulfonamides that are potent and sub-type selective NaV1.7 inhibitors is described.. Optimization of early lead matter focused on removal of structural alerts, improving metabolic stability and reducing cytochrome P450 inhibition driven drug-drug interaction concerns to deliver the desired balance of preclinical in vitro properties.. Concerns over non-metabolic routes of clearance, variable clearance in pre-clinical species and subsequent low confidence human pharmacokinetic predictions led to the decision to conduct a human microdose study to determine clinical pharmacokinetics. |